Compare Vistra Corp (VST) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vistra Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Vistra Corp trades at $162.33 (market cap $53.27B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: Vistra Corp pays a 0.58% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Vistra Corp nearer its low. Which is the better fit depends on your goals.
| VST | XBI | |
|---|---|---|
Market Cap | $53.27B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $217.92 | $164.28 |
52-Week Low | $134.71 | $85.16 |
Enterprise Value | $75.03B | — |
Dividend Yield | 0.58% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
